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Ras proteins are laterally segregated into transient nanoclusters on the plasma 
membrane, a property essential for high fidelity signal transduction through the 
MAPK pathway. From a proteomic screen we identified nucleophosmin (NPM) 
and nucleolin as two novel regulators of K-Ras plasma membrane interactions 
that in turn influence MAP Kinase signaling. NPM and nucleolin are 
predominately nucleolar proteins but also possess extra-nuclear functions. We 
showed that a subset of NPM and nucleolin localize to the inner leaflet of the 
plasma membrane and specifically interact with K-Ras but not H-Ras. This 
interaction is independent of the activation state of K-Ras, and stabilizes K-Ras 
membrane levels. NPM expression also increases the fraction of K-Ras in 
nanoclusters. The increase in clustered K-Ras-GTP enhances signaling through 
the MAPK pathway. Together these results identify NPM and nucleolin as a new 
class of K-Ras regulators that modulate signal transduction via the MAPK 
pathway. 
 
Ras proteins control a diverse range of cellular processes including cell 
proliferation, differentiation and survival. Ras proteins are small GTPases that 
function as molecular switches on the plasma membrane transmitting signals from 
cell surface receptors to the cell interior. They are key modulators of the MAP Kinase 
(MAPK) pathway, delivering high fidelity signal transmission1-3. Critical residues in 
the C-terminal hypervariable region (HVR) confer correct localization and isoform 
specific function on Ras proteins. The minimal membrane anchors of K-Ras, H-Ras 
and N-Ras together with flanking sequences and the G-domain, determine Ras 
interactions with lipids and proteins on the inner leaflet of the plasma membrane, 
leading to isoform-specific signaling output4, 5. Dysregulation of Ras signaling results 
in abnormal cell growth and tumor formation. Mutations are most prevalent in the K-
Ras gene, and are associated with pancreatic, colon, and non-small cell lung cancer6, 7. 
To further understand K-Ras mediated functions, we undertook a proteomic 
screen to identify proteins that specifically interact with K-Ras. This study revealed 
two nucleolar proteins, nucleophosmin (NPM) and nucleolin, as specific K-Ras 
interacting proteins8. Co-immunoprecipitation analysis confirmed that NPM and 
nucleolin specifically bind to K-Ras but not H-Ras in the cell. Domain deletion 
experiments showed that the C-terminal polybasic region of K-Ras binds to the N-
terminal domain of NPM8, excluding a trivial explanation that the interaction between 
K-Ras and NPM is due to electrostatic interactions in vitro between the NPM acidic 
domain and the K-Ras basic domain. NPM and nucleolin are predominately localized 
to the nucleolus but have also been reported to have extra-nuclear functions9-11. 
Importantly, using electron microscopy, we definitively showed a pool of NPM and 
nucleolin localizing to the inner leaflet of the plasma membrane. Compared to the 
nucleolar pool of NPM and nucleolin, the subset of NPM and nucleolin on the plasma 
membrane was in considerably lower abundance. Nonetheless, we show that K-Ras, 
NPM and nucleolin formed a complex in the membrane fraction of cells8.  
This poses the interesting question of what is the role of the NPM, nucleolin, 
K-Ras complex on the plasma membrane. Our data demonstrate that recruitment of 
NPM and nucleolin to the plasma membrane are K-Ras independent events. In 
contrast, over expression of NPM and nucleolin both led to increased overall cellular 
K-Ras protein levels. This also correlated with an increase in plasma membrane 
bound K-Ras,8. Furthermore, we observed increased levels of both GTP and GDP 
loaded K-Ras on the membrane. The interaction between K-Ras and NPM is 
significantly enhanced if farnesylation of K-Ras is blocked by point mutation8. In 
intact cells therefore NPM may preferentially interact with membrane-bound, rather 
than cytosolic K-Ras since the farnesyl moiety that inhibits the interaction will be 
partitioned into the lipid bilayer.  
On the plasma membrane Ras proteins occupy distinct dynamic domains 
called nanoclusters that are critical for functional activity and essential for high 
fidelity signaling through the MAPK pathway1-3. The spatial distribution of K-Ras is 
modulated by its activation state and recent work shows that K-Ras-GTP nanoclusters 
are spatially distinct from K-Ras-GDP nanoclusters12-14. Strikingly, our data showed 
that in addition to stabilizing K-Ras levels on the membrane, overexpression of NPM 
also increased the clustered fraction of both GTP and GDP bound K-Ras, but not the 
size of the nanoclusters. Nucleolin expressed alone did not alter the extent of K-Ras 
clustering, nor did co-expression potentiate the enhanced clustering induced by NPM. 
Therefore, the roles of nucleolin and NPM in modulating K-Ras function appear to be 
distinct. One possibility is that nucleolin operates as a chaperone that facilitates 
delivery of K-Ras to the PM, whereas NPM operates exclusively at the plasma 
membrane to drive K-Ras clustering. In this context the increase in K-Ras plasma 
membrane levels stimulated by nucleolin would reflect increased transport. In contrast 
the increase in K-Ras levels stimulated by NPM would be a direct result of increased 
nanoclustering, since nanoclustered K-Ras is more stably associated with the plasma 
membrane than monomeric K-Ras15.  
Other scenarios however cannot be excluded. For example, nucleolin has 
recently been shown to interact with the cytoplasmic domain and modulate the 
function of ErbB receptors16, 17. It is possible that these activities direct Erb signaling 
through K-Ras. Whatever the molecular mechanisms, consistent with the effects on 
K-Ras plasma membrane levels and nanoclustering, expression of NPM or nucleolin 
alone or in combination increases ERK activation8. In sum, our data shows that a 
subset of NPM and nucleolin bind and stabilize K-Ras on the inner leaflet of the 
plasma membrane. The increase in K-Ras levels on the membrane is synchronized by 
NPM with an increase in the clustered fraction of K-Ras, both GTP and GDP loaded. 
Elevated K-Ras-GTP nanoclusters lead to increased activation of ERK. 
To date, the major scaffold protein shown to associate with K-Ras on the 
plasma membrane is Galectin-3 (Gal-3)15, 18. The interaction between Gal-3 and K-
Ras is prenyl dependent and is restricted to K-Ras-GTP nanoclusters; moreover Gal-3 
is recruited from the cytosol to the membrane by K-Ras-GTP18. In contrast, NPM is 
constitutively associated with the membrane, and interacts with both GDP and GTP 
bound K-Ras8. The significant differences between Gal-3 and NPM suggest that NPM 
is a novel class of regulator of K-Ras plasma membrane interactions. The interplay 
between Gal-3 and NPM regulation of K-Ras is likely critical for control of the 
MAPK pathway. Many details remain to be worked out. We favor the idea that 
plasma membrane level of NPM sets a basal level of K-Ras clustering, whereas the 
cytosolic levels of Gal-3 determine the clustered fraction of K-Ras-GTP after K-Ras 
activation. We have speculated that modulating the basal level of K-Ras clustering 
may have a role in driving MAPK activation during M phase of cell cycle, when 
extranuclear levels of NPM increase with breakdown of the nuclear envelope8. In 
contrast, elevated levels of cytosolic Gal-3, as occur in many malignancies will 
increase the number of K-Ras-GTP nanoclusters for any given amount of K-Ras-GTP, 
amplifying MAPK output15. 
It is also important to highlight that like Gal-3, NPM and nucleolin are 
overexpressed in many cancers19. In particular, 35% of adult acute myeloid leukemia 
cases have a frameshift mutation in the NPM gene that results in aberrant 
redistribution of NPM to the cytoplasm20, 21. Based on our results, one intriguing 
possibility is that the overexpressed and/or mislocalized NPM partitions to the plasma 
membrane leading to increased K-Ras nanoclustering and elevated K-Ras signaling. 
Therefore it is imperative we understand the mechanism of NPM and nucleolin 
targeting and how it correlates with oncogenesis.    
 
Figure Legend 
Figure 1. Proposed model for the role of NPM, nucleolin (NCL) and Gal-3 on K-Ras 
function. (A) (1) Nucleolin operates as a chaperone to facilitate delivery of K-Ras to 
the plasma membrane. NPM and nucleolin specifically interact with K-Ras on the 
plasma membrane to stabilise K-Ras levels. (2) NPM alone or NPM in complex with 
nucleolin increase the amount of K-Ras-GDP and K-Ras-GTP in nanoclusters. (3) 
Elevated signaling by K-Ras-GTP leads to increased ERK activation. (B) (1) 
Cytosolic Gal-3 is recruited to the plasma membrane after EGF stimulation of the cell. 
(2) Gal-3 increases K-Ras-GTP nanoclustering (3) which leads to increased ERK 
activation. 
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